Unnatural Products Announces Multi-Target Collaboration with argenx to Develop Oral Macrocyclic Peptide Therapeutics
Unnatural Products Announces Multi-Target Collaboration with argenx to Develop Oral Macrocyclic Peptide Therapeutics GlobeNewswire July 01, 2025 – UNP to receive a double digit million dollar upfront payment, near-term payments and up to approximately $1.5B in potential milestone payments plus royalties – Partnership will harness UNP's AI enhanced macrocycle platform to drug historically “undruggable” targets […]